logo
Is being born as an LGBTI person a medical issue?

Is being born as an LGBTI person a medical issue?

Bangkok Post29-06-2025
June is a propitious time to remember the history of lesbian, gay, transgender and intersex (LGBTI) people and their struggles to overcome discrimination and violence. One of the difficulties confronting them throughout the ages has been how the medical sector and related science view them, and how they should be treated by medical classifications. What is the situation today both locally and globally?
On the positive front, there is the medical issue facing the LGBTI community and everyone else in terms of their right to healthcare and related access. Thailand can be proud that it aspires to provide universal healthcare, whereby people can access the highest attainable standard of health, to the maximum extent of available resources.
The so-called 30-baht medical care system, with little to be paid for medical services as social protection for all Thais, has been recognised worldwide. Of course, there is room for improvement, such as making the system more efficient and more comprehensive in regard to gender diversity, but it is undeniable that medical care has been one of the key successes in policy planning and practice for the past two decades.
On another front, there is more room for debate. At the topmost level of the global health system, it should not be forgotten that even in the medical arm of the UN, gays and lesbians were seen as having a mental disorder till 1990. This embodied a pathological approach that viewed gender diversity as an abnormality, illness or disorder. The shift in mindset in the 1990s helped to "depathologise" in regard to gays and lesbians. Being gay or lesbian is simply a part of human biodiversity, not a disorder. In Thailand, it took the medical sector several years to adjust to that catalytic change.
Regrettably, over 60 countries still criminalise same-sex relations, particularly affecting LGBTI groups. The authorities of some countries still oblige parents to take their children to psychiatrists to change their sexual orientation and gender identity as part of "conversion therapy". Today, several countries are adopting laws against conversion therapy, and judicial intervention in a big Asian country has significantly prohibited such practice.
The medical approach towards transgender people has also been problematic. Previously, the International Classification of Diseases (ICD) under the World Health Organization, a UN agency, viewed transgender people as having a disorder.
Words such as "gender disorder" and "gender dysphoria" were used nationally and internationally to describe the group, compounding the stigma and discrimination against them. This was tantamount to the "pathologisation" of gender diversity emanating from the medical sector, shaping the public perception.
It was only in 2019 that the agency started to depathologise with regard to the classification of transgender people. The revamped ICD was to classify the group as not having a mental disorder but having an issue of "sexual health". This was an improvement, shifting from the previous pathology-based perception.
While this was a progressive stepping stone, some terms in the newer ICD are still ambivalent. For example, phrases such as "gender incongruence of adolescence and adulthood" and "gender incongruence of childhood" appear in the new text covering transgender people. On the one hand, these terms are justified by some quarters as enabling a diagnostic link to enable access to healthcare. On the other hand, from a less medical perspective, even the term "incongruence" might be seen to be stigmatising and discriminatory.
Interestingly, in Thailand, over a decade ago, a dilemma arose concerning the military conscription form which, at the time, classified transgender people as persons with a mental disorder. That classification was problematic, and there was a case before the Administrative Court to invalidate the terminology. The court agreed, and the military proposed to change the classification to "current sex status does not match that of birth". That description is more respectful of gender diversity.
Incidentally, when people undergo surgery to self-identify as transgender, the preferred term is "gender affirmation" rather than "gender reassignment".
There remains a challenging spectrum concerning intersex people who have particular characteristics, with sometimes both male and female organs. A United Nations-related description is as follows: "Intersex people are born with sex characteristics (such as sexual anatomy, reproductive organs, hormonal patterns and/or chromosomal patterns) that do not fit typical binary notions of male or female bodies." This group was raised as a key concern for discussion with the UN Human Rights Council last year and this will be continued this year.
The description found in medical practice is that the group has "disorders of sex development". From the angle of biodiversity, that term is not empathetic. Other terms, such as "variations of sex characteristics", "differences of sex development" or simply "intersex", are regarded as more balanced. With this group, it is important that doctors and parents refrain from deciding on behalf of the child at an early stage and subjecting the child to a medical procedure, choosing the sex/gender of the child. Such a procedure should be left to a later stage when the child has grown up, with due respect for the person's choice.
At a seminar with doctors in which this author participated in Bangkok recently, doctors said they advise parents should wait and not hasten the decision-making until the child reaches a suitable age. In a draft Thai law on this issue, 15 years old is the proposed minimum age for exercising the choice for the procedure.
Given that Thai doctors are at the forefront of universal healthcare with key contributions at the international level, they should leverage well to overcome the stigma and discriminatory remnants of medical classifications and procedures globally.
On a related front, another key initiative which Thailand can propel as a member of the UN Human Rights Council is to vote this year for the extension of the mandate of the UN Independent Expert on Sexual Orientation and Gender Identity as a global monitor of these issues. Without equivocation, the authorities should not abstain but vote "Yes", exhibiting exemplary leadership for progressive, gender-diverse transformative change.
Vitit Muntarbhorn is a Professor Emeritus at Chulalongkorn University. He has helped the UN as a UN Special Rapporteur, UN Independent Expert and member of the UN Commissions of Inquiry on Human Rights.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MSF warns acute malnutrition soaring in Gaza
MSF warns acute malnutrition soaring in Gaza

Bangkok Post

timea day ago

  • Bangkok Post

MSF warns acute malnutrition soaring in Gaza

GENEVA - Doctors Without Borders warned Friday that its teams on the ground in Gaza were witnessing surging levels of acute malnutrition in the besieged and war-ravaged Palestinian territory. The medical charity, known by its French acronym MSF, said levels of acute malnutrition had reached an "all-time high" at two of its facilities in the Gaza Strip. "MSF teams are witnessing a sharp and unprecedented rise in acute malnutrition among people in Gaza," the organisation said in a statement. "In Al-Mawasi clinic, southern Gaza, and the MSF Gaza Clinic in the north, we are seeing the highest number of malnutrition cases ever recorded by our teams in the Strip." MSF said it now had more than 700 pregnant and breastfeeding women and nearly 500 children with severe and moderate malnutrition currently enrolled in ambulatory therapeutic feeding centres in both clinics. The numbers at the Gaza City clinic had almost quadrupled in under two months, from 293 cases in May to 983 cases at the start of this month, it said. "This is the first time we have witnessed such a severe scale of malnutrition cases in Gaza," Mohammed Abu Mughaisib, MSF's deputy medical coordinator in Gaza, said in the statement. - 'Intentional' starvation - "The starvation of people in Gaza is intentional," he charged, insisting that "it can end tomorrow if the Israeli authorities allow food in at scale". Starting in March, Israel blocked deliveries of food and other crucial supplies into Gaza for more than two months, leading to warnings of famine across a territory widely flattened by Israeli bombing since Hamas's deadly October 7, 2023 attack on Israel. Israel began allowing food supplies to trickle in at the end of May, but using a new US- and Israel-backed organisation called the Gaza Humanitarian Foundation (GHF). That group's operations, which effectively sidelined a vast UN aid delivery network in Gaza, have been marred by chaotic scenes and near-daily reports of Israeli forces firing on people waiting to collect rations. The UN said Friday that at least 615 people had been killed in the vicinity of GHF sites since May 27. The organisation itself denies that fatal shootings have occurred in the immediate vicinity of its aid points. MSF maintained Friday that "the existence of malnutrition in Gaza is the result of deliberate, calculated choices by the Israeli authorities". They have decided, it said, to "restrict the entry of food to the bare minimum for survival, dictate and militarise the means of its subsequent distribution, all while having destroyed the majority of local food production capacity". MSF described how injured patients at its clinics warned that its malnourished patients were "begging for food instead of medicine, their wounds failing to close due to protein deficiency". Far more babies were also being born prematurely, while six-month pregnant women often weighed no more than 40 kilos (88 pounds), it said.

Novo Nordisk Brings Cities for Better Health to Bangkok
Novo Nordisk Brings Cities for Better Health to Bangkok

Bangkok Post

time2 days ago

  • Bangkok Post

Novo Nordisk Brings Cities for Better Health to Bangkok

Bangkok, July 11, 2025 — Following a visit to Copenhagen, Denmark, to collaborate on enhancing urban health, the Bangkok Metropolitan Administration (BMA) and Novo Nordisk will launch the Cities for Better Health (CBH) programme in Bangkok in 2025. The BMA delegation, led by Governor Chadchart Sittipunt, was supported by the Ministry of Foreign Affairs of Denmark and introduced to best practices in sustainable urban development, circular economy models, and health promotion through public-private partnerships. During the visit, the delegation explored Spor 10, a CBH programme site in central Copenhagen developed by Novo Nordisk. This innovative initiative has successfully transformed an underutilised area into a vibrant and healthy community space, featuring a basketball court, outdoor gym equipment, and other recreational zones that promote community engagement and safe, enjoyable physical activity. Spor 10 exemplifies the power of collaboration among the public and private sectors, civil society, and international organisations in fostering healthier urban communities. 'By learning from a pioneer in healthy urban development such as Spor 10 in Copenhagen, the BMA can replicate similar public-private partnerships for the benefit of Bangkok residents,' said Governor Chadchart. 'The CBH programme will empower our citizens to lead healthier lives and embrace more active lifestyles within their communities.' The delegation also met with representatives from Novo Nordisk, Denmark's Gladsaxe Municipality, and the C40 network. Discussions focused on the CBH programme and the development of community spaces that foster social interaction and promote active living, aligned with C40 initiatives such as the Green and Thriving Neighbourhoods programme. Governor Chadchart also highlighted the transformation of Benjakitti Park in Bangkok, where a former tobacco factory was converted into an expansive green public space. He expressed a strong interest in implementing the CBH model in the Thai capital. Implemented in more than 50 cities worldwide, the Cities for Better Health programme promotes healthy lifestyles and aims to prevent chronic diseases through a holistic and sustainable approach powered by cross-sector partnerships. With over 40% of Thais living with overweight or obesity—and approximately 57% of Bangkok adults affected—the need to 'bend the curve' on chronic diseases has never been more urgent. As part of efforts to address obesity in the capital, Novo Nordisk has been working closely with the BMA to implement CBH-related projects in 2025, with a strong focus on prevention and health equity. H.E. Mr Danny Anan, Danish Ambassador to Thailand, remarked, 'Copenhagen has been ranked the world's most liveable city in 2025. Denmark and Thailand share a common vision for healthy urban living. The collaboration between Novo Nordisk and Thai authorities such as the BMA reflects the strong and dynamic relations between our nations.' Ms Selina Christodoulakis, Director of Market Access and Public Affairs at Novo Nordisk Thailand, added, 'Novo Nordisk is proud to support health initiatives alongside our partners in Thailand. The CBH programme reflects our ongoing commitment to improving health outcomes and fostering sustainable practices in urban environments, where chronic diseases have the greatest impact. We look forward to working collaboratively to place Bangkok firmly on the CBH network map.'

New drug to be registered with FDA
New drug to be registered with FDA

Bangkok Post

time04-07-2025

  • Bangkok Post

New drug to be registered with FDA

The Government Pharmaceutical Organisation (GPO) has prepared to register the affordable hepatitis C drug ravidasvir with the Food and Drug Administration to improve access for 800,000 patients and reduce treatment costs. GPO director Dr Mingkwan Suphanpong said on Thursday that the state producer is working with the Drugs for Neglected Diseases initiative (DNDi) and Egypt‑based Pharco Pharmaceuticals, which co‑developed ravidasvir under a South‑South partnership. The three parties have signed a memorandum of understanding to supply technical documents and regulatory support "so the registration proceeds smoothly", she said. Four clinical trials conducted in Bangkok, Chiang Mai, and Malaysia show that ravidasvir achieves cure rates above 95%. Already registered in Malaysia and listed on the World Health Organization's essential medicines roster, the drug will become Thailand's first domestically produced direct‑acting antiviral (DAA) developed through international collaboration, said Dr Mingkwan. "Current DAA regimens cost more than 2.5 million baht, so many patients are left untreated," she said. Only about one in five Thais with the virus can presently afford therapy, she added, yet untreated infection can progress to liver cancer, cirrhosis and chronic disease, burdening families and the health‑care budget. Ravidasvir's registration is a central plank of Thailand's strategy to eliminate hepatitis C by 2030. DNDi, an NGO dedicated to affordable medicines in developing nations, and Pharco, which supplies the active pharmaceutical ingredient, will continue to assist GPO in scaling up production once regulatory clearance is secured, she said. Dr Mingkwan said a Thai‑made version of ravidasvir would "dramatically lower prices and expand access".

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store